Unihealth Consultancy
Unihealth Consultancy Performance
Day Range
- Low 127.30
- High 131.50
52 Week Range
- Low 116.20
- High 147.00
- Open Price130.55
- Previous Close131.90
- Volume77000
Start SIP in Unihealth Consultancy
Start SIPUnihealth Consultancy Investment Rating
-
Master Rating:
-
Unihealth Consultancy Ltd has an operating revenue of Rs. 106.98 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 21% is great, ROE of 27% is exceptional. The company has a high debt to equity of 130%, which can be a reason to worry. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 20 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 137 indicates it belongs to a poor industry group of Medical-Managed Care and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Mar 2022 |
|---|---|---|
| Total Revenue Annual Cr | 4 | 3 |
| Operating Expenses Annual Cr | 1 | 1 |
| Operating Profit Annual in Cr | 1 | 1 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 1 | 1 |
| Tax Annual Cr | 0 | 0 |
| Net Profit Annual Cr | 1 | 0 |
Unihealth Consultancy Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹135.35
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹136.37
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
Unihealth Consultancy Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 132.23 |
| Second Resistance | 133.97 |
| Third Resistance | 136.43 |
| RSI | 41.52 |
| MFI | 35.67 |
| MACD Single Line | 1.58 |
| MACD | 0.33 |
| Support | |
|---|---|
| First Resistance | 128.03 |
| Second Resistance | 125.57 |
| Third Resistance | 123.83 |
Unihealth Consultancy Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 77,000 | 5,000,380 | 64.94 |
| Week | 54,500 | 3,649,865 | 66.97 |
| 1 Month | 62,286 | 4,928,669 | 79.13 |
| 6 Month | 40,344 | 3,538,572 | 87.71 |
Unihealth Consultancy Result Highlights
Unihealth Consultancy Synopsis
NSE-Medical-Managed Care
Unihealth Consultanc belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 1.92 Cr. and Equity Capital is Rs. 1.39 Cr. for the Year ended 31/03/2023. Unihealth Consultancy Ltd. is a Public Limited Listed company incorporated on 26/02/2010 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U85100MH2010PLC200491 and registration number is 200491.| Market Cap | 201 |
| Sales | 2 |
| Shares in Float | 0.48 |
| No of funds | 8 |
| Yield |
| Book Value | 1.43 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 88 |
| Alpha | -0.09 |
| Beta | 0.88 |
Unihealth Consultancy
| Owner Name | Sep-23 |
|---|---|
| Promoters | 68.8% |
| Insurance Companies | 0.12% |
| Foreign Portfolio Investors | 5.61% |
| Financial Institutions/ Banks | 0.23% |
| Individual Investors | 15.98% |
| Others | 9.26% |
Unihealth Consultancy Management
| Name | Designation |
|---|---|
| Dr. Akshay Parmar | Managing Director |
| Dr. Anurag Shah | Executive Director |
| Mr. Parag Shah | Whole Time Director |
| Dr. Harsh Sheth | Independent Director |
| Ms. Riddhi Javeri | Independent Director |
| Dr. Jagat Shah | Independent Director |
Unihealth Consultancy Forecast
Price Estimates
Unihealth Consultancy Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-08 | Quarterly Results |
Unihealth Consultancy FAQs
What is Share Price of Unihealth Consultancy ?
Unihealth Consultancy share price is ₹130 As on 03 December, 2023 | 03:34
What is the Market Cap of Unihealth Consultancy ?
The Market Cap of Unihealth Consultancy is ₹201 Cr As on 03 December, 2023 | 03:34
What is the P/E ratio of Unihealth Consultancy ?
The P/E ratio of Unihealth Consultancy is As on 03 December, 2023 | 03:34
What is the PB ratio of Unihealth Consultancy ?
The PB ratio of Unihealth Consultancy is 7.4 As on 03 December, 2023 | 03:34